Morgan Stanley Karyopharm Therapeutics Inc. Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Morgan Stanley holds 3,513,188 shares of KPTI stock, worth $2.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,513,188

Previous 123,647 2741.3%

Holding current value

$2.18 Million

Previous $102,000 2241.18%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.6 - $0.99 $2.03 Million - $3.36 Million	3,389,541 Added 2741.3%	3,513,188 $2.39 Million
Q3 2024 Nov 14, 2024	SELL	$0.7 - $1.06 $53,452 - $80,942	-76,361 Reduced 38.18%	123,647 $102,000
Q2 2024 Oct 17, 2024	SELL	$0.87 - $1.58 $82,457 - $149,750	-94,779 Reduced 32.15%	200,008 $174,000
Q2 2024 Aug 14, 2024	SELL	$0.87 - $1.58 $82,457 - $149,750	-94,779 Reduced 32.15%	200,008 $174,000
Q1 2024 Oct 17, 2024	BUY	$0.72 - $1.66 $68,240 - $157,333	94,779 Added 47.39%	294,787 $445,000
Q1 2024 Aug 16, 2024	SELL	$0.72 - $1.66 $396,262 - $913,604	-550,364 Reduced 65.12%	294,787 $445,000
Q1 2024 May 15, 2024	SELL	$0.72 - $1.66 $396,262 - $913,604	-550,364 Reduced 65.12%	294,787 $445,000
Q4 2023 Aug 16, 2024	BUY	$0.68 - $1.31 $438,697 - $845,137	645,143 Added 322.56%	845,151 $726,000
Q4 2023 Feb 13, 2024	SELL	$0.68 - $1.31 $135,537 - $261,109	-199,320 Reduced 19.08%	845,151 $726,000
Q3 2023 Nov 15, 2023	BUY	$1.14 - $1.81 $709,256 - $1.13 Million	622,155 Added 147.32%	1,044,471 $1.4 Million
Q2 2023 Aug 14, 2023	SELL	$1.79 - $4.59 $544,829 - $1.4 Million	-304,374 Reduced 41.88%	422,316 $755,000
Q1 2023 May 15, 2023	SELL	$2.84 - $3.92 $1.6 Million - $2.21 Million	-562,747 Reduced 43.64%	726,690 $2.83 Million
Q4 2022 Feb 14, 2023	BUY	$2.48 - $5.93 $519,698 - $1.24 Million	209,556 Added 19.41%	1,289,437 $4.38 Million
Q3 2022 Nov 14, 2022	SELL	$4.08 - $5.82 $5.33 Million - $7.61 Million	-1,306,817 Reduced 54.75%	1,079,881 $5.9 Million
Q2 2022 Oct 27, 2022	SELL	$4.15 - $8.37 $1.77 Million - $3.56 Million	-425,865 Reduced 15.14%	2,386,698 $10.8 Million
Q2 2022 Aug 15, 2022	SELL	$4.15 - $8.37 $1.77 Million - $3.56 Million	-425,865 Reduced 15.14%	2,386,698 $10.8 Million
Q1 2022 Oct 27, 2022	BUY	$5.91 - $14.38 $2.52 Million - $6.12 Million	425,865 Added 17.84%	2,812,563 $20.7 Million
Q1 2022 May 13, 2022	BUY	$5.91 - $14.38 $10.3 Million - $25.1 Million	1,746,944 Added 163.94%	2,812,563 $20.7 Million
Q4 2021 Feb 14, 2022	SELL	$5.21 - $8.61 $4.31 Million - $7.12 Million	-827,314 Reduced 43.71%	1,065,619 $6.85 Million
Q3 2021 Nov 15, 2021	BUY	$4.45 - $10.63 $8.42 Million - $20.1 Million	1,892,933 New	1,892,933 $11 Million

Others Institutions Holding KPTI

# of Institutions

Shares Held

59.6M

Call Options Held

547K

Put Options Held

67K

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $49.5M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account